-
Acorda Submits New Drug Application to U.S. Food and Drug Administration for INBRIJA
firstwordpharma
June 30, 2017
Acorda Submits New Drug Application to U.S. Food and Drug Administration for INBRIJA
-
FDA creates team to tackle backlog of orphan drug designation requests
firstwordpharma
June 30, 2017
FDA creates team to tackle backlog of orphan drug designation requests
-
Experimental Drug Shows Promise Against Dangerous Viruses
drugs
June 30, 2017
An experimental antiviral drug is effective against a number of coronaviruses, including some that can cause deadly epidemics, researchers say.
-
Experimental sickle cell disease drug gets PRIME status
pharmatimes
June 30, 2017
Global Blood Therapeutics’ GBT440 has become the first potential treatment for sickle cell disease to be accepted onto the European Medicines Agency’s regulatory support programme PRIME.
-
Vetter, Microdermics Enter Strategic Drug Delivery Alliance
contractpharma
June 01, 2017
To develop microneedle drug delivery systems
-
How Merck & Co. (MRK) Could Have Lucked Into a $10 Billion Drug
BioSpace.com
May 15, 2017
The stars have lined up for Merck (MRK) as analysts suggest its checkpoint inhibitor Keytruda could yield $6 billion in revenue in 2018 and could grow to $10 billion by 2022.
-
New collaborative project launched to engage universities in drug discovery for neglected diseases
pharmaceutical-technology
May 08, 2017
A new collaborative project has been launched to engage students from five universities in the US, the UK and India to help discover new drugs for neglected diseases.
-
Pfizer offers breast cancer drug for free following NICE rejection
pharmafile
May 08, 2017
The drug was knocked back by NICE over concerns over the significance of its clinical efficacy in improving overall ...
-
Perrigo offices searched by US Justice Department in drug pricing probe
pharmaceutical-technology
May 05, 2017
Generics maker Perrigo has reported that its corporate offices were searched by the agents of the US Department of ...
-
European Commission warns UK over drug authorisation validity due to Brexit
pharmafile
May 05, 2017
The European Commission has issued a warning to pharmaceutical firms in the UK over the validity of current and future drug authorisations in the wake of Brexit.